In terms of Regulation 23(9) of the Securities and Exchange Board Of India (Listing Obligations and Disclosure Requirements) Regulations, we enclose disclosure of Related Party Transaction on consolidated basis , in the format specified in the accounting standards for the half year ended September 30, 2020
Mercury Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2020 ,inter alia, to consider and approve the Unaudited financial results of the Company for the quarter & half year ended on September 30, 2020 along with following and other items of agenda. 1.To consider and to approve Unaudited Financial results of the Company for the Quarter & Half Year ended on September 30, 2020. 2.To consider and approve any other items of Agenda, if any You are therefore requested to take the above information on records and disseminate information to stakeholders of the Company.
With reference to above subject, we are submitting herewith Compliance Certificate pursuant to Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 signed by the compliance officer of the Company and authorized representative of M/s. Link Intime India Private Limited, Share Transfer Agents of the Company for the half year ended on September 30, 2020. You are requested to take the above information on record.